Memorial Sloan Kettering, Genentech, Jiahui Health To Join Forbes China Healthcare Summit On Aug. 15
Russell Flannery, Forbes, July 30, 2020
Forbes China is set to host its inaugural “Forbes China Healthcare Summit” on August 15, 2020, with a focus on “Advancing the Global Fight Against Cancer in the COVID-19 Pandemic Era.” The summit aims to address the significant impact of cancer globally, especially in China, where it is projected to cause three million deaths. Additionally, the susceptibility of cancer patients to COVID-19, leading to a higher mortality rate, will be discussed during the event.
The event, organized in collaboration with Memorial Sloan Kettering Cancer Center in New York, will feature key participants including Steve Forbes, Chairman of Forbes, Moira Forbes, Hon. Kevin Rudd – President of Asia Society Policy Institute and former Prime Minister of Australia, along with renowned medical professionals like Dr. Lisa DeAngelis and Bob Li from Memorial Sloan Kettering Cancer Center. The agenda encompasses critical aspects such as patient care, research, regulatory policies, and philanthropy in the fight against cancer.
Among the sponsors of the event are industry leaders like Genentech, Novartis, the Antidote Health Foundation, and Jiahui International Hospital. The summit will kick off on Friday, August 14, 8 p.m. EST in the U.S. and on Saturday, August 15, 8 a.m. in China. Topics of discussion will include collaboration opportunities and challenges within the global cancer fight. Interested participants can register for the event through provided links, and for further inquiries, they can reach out to Kelly Ang via the contact details listed in the article.
Forbes China, a platform dedicated to celebrating success and highlighting influential leaders globally, aims to curate impactful events like the healthcare summit to drive change and transformation in the business and medical landscape. The event promises to gather key stakeholders and decision-makers in the healthcare sector to deliberate on strategies for improving cancer outcomes and addressing the unique challenges posed by the COVID-19 pandemic.
For more information, please visit the Forbes website.